MedTrace Logo

Level of HER2-neu Gene Amplification an Response to Trastuzumab

NCT00874146 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-09-02

No results posted yet for this study

Summary

Primary objective of the study is to evaluate the correlation between level of HER2-neu gene amplification evalued by dual-color Fluorescent in-situ hybridization (FISH) test and time to progression (TTP) in patients with HER2-positive advanced breast cancer treated with trastuzumab-containing regimens.

Conditions

Interventions

GENETIC

Fluorescent in-situ hybridization (FISH)

Dual color FISH test to assess ratio of HER2/neu amplification

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Armando Santoro, MD · Istituto Clinico Humanitas

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-09-30
Completion
2009-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874146 on ClinicalTrials.gov